Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
March 12, 2026
Biotechnology
-
-
Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences
March 12, 2026
-
Corporate Update: Psyence BioMed Advances Vertically Integrated Pharmaceutical Platform Following PsyLabs Export Milestone
March 11, 2026
-
Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
March 11, 2026
-
SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails
March 10, 2026
-
Longeveron Announces Private Placement of up to $30 Million
March 10, 2026
-
MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026
March 9, 2026
-
Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026
March 9, 2026
-
Solid Biosciences Announces Oversubscribed $240 Million Private Placement
March 6, 2026
-
Immuneering Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
March 6, 2026
-
PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights
March 6, 2026
-
Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types
March 5, 2026
-
CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab
March 5, 2026
-
AIM ImmunoTech Announces Expiration and Preliminary Results of its Rights Offering for Aggregate Gross Proceeds of $1.8 Million
March 4, 2026
-
Hoth Therapeutics Deploys OpenAI API to Advance Development of Orphan HT-KIT Oncology Program
March 4, 2026
-
Ocugen Provides Business Update with Fourth Quarter and Full Year 2025 Financial Results
March 4, 2026